Back to search

Article

Alzheimer’s disease as a form of in situ diabetes: A systematic review and meta-analysis of therapeutic approaches using intranasal insulin treatment

2024-06-25

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Introduction</h4> Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that is characterized by the loss of memory, language, and other cognitive functions. Increasing evidence suggests that AD shares pathophysiological similarities with type 2 diabetes, leading to the concept of AD as “diabetes in situ” within the brain. Intranasal insulin (INI) for AD has emerged as a promis...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5326fc36-3745-515c-ac65-b511d55b2e59
DOI
10.1101/2024.06.21.24309323
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Alzheimer’s disease as a form of in situ diabetes: A systematic review and meta-analysis of therapeutic approaches using intranasal insulin treatmentDOI 10.1101/2024.06.21.24309323
Incidence and Risk of Alzheimer’s Disease in Individuals with Type 2 Diabetes: A Systematic Review and Meta-AnalysisSemantic proximity
Epigenetic Alterations in Alzheimer’s Disease: Impact on Insulin Signaling and Advanced Drug Delivery SystemsSemantic proximity
Link between Diabetes and Alzheimer’s Disease Due to the Shared Amyloid Aggregation and Deposition Involving Both Neurodegenerative Changes and Neurovascular DamagesSemantic proximity
Therapy-Driven Trajectories of Complications in Type 2 Diabetes Mellitus: A Comparative Observational Study of Standalone and Integrated Pharmacotherapy in a Tertiary Care Teaching HospitalSemantic proximity
Risk of Alzheimer's Disease in People with Diabetes MellitusSemantic proximity
Metformin Shows Greater Potential Than Semaglutide in Reducing Alzheimer’s Risk in Diabetes Type II via Dual Actions: Tackling Disease Pathways and Environmental Herpesvirus TriggersSemantic proximity
Insulin Resistance and Metabolic Comorbidities in Alzheimer’s DiseaseSemantic proximity
Insulin in Amyotrophic Lateral Sclerosis: Impairment, Tests and TreatmentSemantic proximity
Oral Blarcamesine Phase IIb/III Trial Confirms Identified Precision Medicine Patient Population – Significant Broad Clinical and Quality of Life Improvements for Early Alzheimer’s Disease PatientsSemantic proximity
Incidence and synergistic Association of Type 2 diabetes and apolipoprotein E epsilon 4 with dementia risk in the Kunshan aging research with E-health cohort study.Semantic proximity
Insulin dysfunction and Tau pathologySemantic proximity
Intranasal Insulin Mediates Neurodegeneration in Diabetic Retinopathy via Regulation of Inflammatory and Apoptotic PathwaysSemantic proximity
Select a neighboring publication to make it the new centre.